>> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. 상품명 정보
  2. GC47042 Carfilzomib-d8

    카르필조미브 양적 분석을 위한 내부 표준제품

    Carfilzomib-d8  Chemical Structure
  3. GN10733 Carnosic acid Carnosic acid  Chemical Structure
  4. GC45679 Carubicin Carubicin(Carminomycin)은 미생물 유래 화합물입니다. Carubicin  Chemical Structure
  5. GC64110 Carubicin hydrochloride 카루비신 염산염은 미생물 유래 화합물입니다. Carubicin hydrochloride  Chemical Structure
  6. GC35612 Carvacrol Carvacrol은 Thymus mongolicus Ronn에서 분리된 모노테르페노이드 페놀입니다. Carvacrol  Chemical Structure
  7. GC62442 Casein Kinase inhibitor A51 카제인 키나제 억제제 A51은 강력하고 경구 활성인 카제인 키나제 1α(CK1α) 억제제입니다. Casein Kinase inhibitor A51은 백혈병 세포사멸을 유도하고 강력한 항백혈병 활성을 갖는다. Casein Kinase inhibitor A51  Chemical Structure
  8. GC32841 Catechin ((+)-Catechin) 카테킨((+)-카테킨)((+)-카테킨((+)-카테킨))은 1.4 μ의 IC50으로 사이클로옥시게나제-1(COX-1)을 억제합니다. Catechin ((+)-Catechin)  Chemical Structure
  9. GN10543 caudatin caudatin  Chemical Structure
  10. GC43149 CAY10404 CAY10404는 IC50이 1nM이고 선택도 지수(SI; COX-1 IC50/COX-2 IC50)가 >500000인 강력하고 선택적인 시클로옥시게나제-2(COX-2) 억제제입니다. CAY10404  Chemical Structure
  11. GC43150 CAY10406 CAY10406 is a trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases 3 and 7. CAY10406  Chemical Structure
  12. GC43154 CAY10443 Mitochondrial release of cytochrome c triggers apoptosis via the assembly of a multimeric complex including caspase-9, Apaf-1, and other components, sometimes called the apoptosome. CAY10443  Chemical Structure
  13. GC43176 CAY10575 CAY10575(화합물 8)는 IC50이 0.075 μ인 IKK2 억제제입니다. CAY10575  Chemical Structure
  14. GC18530 CAY10616 Resveratrol is a natural polyphenolic antioxidant that has anti-cancer properties. CAY10616  Chemical Structure
  15. GC41317 CAY10625 Survivin is a cellular protein implicated in cell survival by interacting with and inhibiting the apoptotic function of several proteins including Smac/DIABLO, caspase-3, and caspase-7. CAY10625  Chemical Structure
  16. GC43189 CAY10681 Inactivation of the tumor suppressor p53 commonly coincides with increased signaling through NF-κB in cancer. CAY10681  Chemical Structure
  17. GC43190 CAY10682 (±)-Nutlin-3 blocks the interaction of p53 with its negative regulator Mdm2 (IC50 = 90 nM), inducing the expression of p53-regulated genes and blocking the growth of tumor xenografts in vivo. CAY10682  Chemical Structure
  18. GC40650 CAY10706 CAY10706 is a ligustrazine-curcumin hybrid that promotes intracellular reactive oxygen species accumulation preferentially in lung cancer cells. CAY10706  Chemical Structure
  19. GC43198 CAY10717 CAY10717 is a multi-targeted kinase inhibitor that exhibits greater than 40% inhibition of 34 of 104 kinases in an enzymatic assay at a concentration of 100 nM. CAY10717  Chemical Structure
  20. GC43203 CAY10726 CAY10726 is an arylurea fatty acid. CAY10726  Chemical Structure
  21. GC46113 CAY10744 A topoisomerase II-α poison CAY10744  Chemical Structure
  22. GC47053 CAY10746 A ROCK1 and ROCK2 inhibitor CAY10746  Chemical Structure
  23. GC48392 CAY10747 An inhibitor of the Hsp90-Cdc37 protein-protein interaction CAY10747  Chemical Structure
  24. GC47055 CAY10749 CAY10749 (화합물 15)는 PARP-1에 대한 8.22, 8.44, 8.25, 6.54, 8.13, 6.08의 PIC50 값을 갖는 강력한 PARP/PI3K 억제제이다. offlineefficient_models_2022q2.md.en_ko_2021q1.mdCAY10749 is a highly effective anticancer compound targeted against a wide range of oncologic diseases.en_ko_2021q1.md CAY10749  Chemical Structure
  25. GC47057 CAY10755 A fungal metabolite with anticancer activity CAY10755  Chemical Structure
  26. GC47061 CAY10763 A dual inhibitor of IDO1 and STAT3 activation CAY10763  Chemical Structure
  27. GC47065 CAY10773 A derivative of sorafenib CAY10773  Chemical Structure
  28. GC49080 CAY10786 CAY10786(화합물 43)은 IC50이 0.63 μ인 GPR52 길항제입니다. CAY10786  Chemical Structure
  29. GC52245 CAY10792 An anticancer agent CAY10792  Chemical Structure
  30. GC14634 CBL0137 curaxin that activates p53 and inhibits NF-κB CBL0137  Chemical Structure
  31. GC15394 CBL0137 (hydrochloride) CBL0137(염산염)은 히스톤 샤페론인 FACT의 억제제입니다. CBL0137(염산염)은 또한 p53을 활성화하고 각각 0.37 및 0.47μM의 EC50으로 NF-κB를 억제할 수 있습니다. CBL0137 (hydrochloride)  Chemical Structure
  32. GC61636 CBR-470-2 글리신 치환 유사체인 CBR-470-2는 NRF2 신호전달을 활성화할 수 있습니다. CBR-470-2  Chemical Structure
  33. GC13648 CC-223 CC-223(CC-223)은 mTOR 키나제의 IC50 값이 16nM인 강력하고 선택적이며 경구 생체이용 가능한 mTOR 키나제의 억제제입니다. CC-223은 mTORC1과 mTORC2를 모두 억제합니다. CC-223  Chemical Structure
  34. GC39169 CC-92480 CC-92480(CC-92480), 세레블론 E3 유비퀴틴 리가제 조절 약물(CELMoD)은 분자 접착제 역할을 합니다. CC-92480은 소뇌에 높은 친화력을 보여 강력한 항골수종 활성을 나타냅니다. CC-92480  Chemical Structure
  35. GC19088 CC122 CC122(CC 122)는 경구 활성 대뇌 조절제입니다. CC122  Chemical Structure
  36. GC61532 CCI-007 CCI-007은 민감한 세포에서 IC50 값이 2.5-6.2μM인 MLL 재배열이 있는 유아 백혈병에 대한 세포독성 활성을 갖는 소분자입니다. CCI-007  Chemical Structure
  37. GC12891 CCT007093 CCT007093은 효과적인 단백질 포스파타제 1D(PPM1D Wip1) 억제제입니다. Wip1 억제는 mTORC1 경로를 활성화하고 간절제술 후 간세포 증식을 향상시킬 수 있습니다. CCT007093  Chemical Structure
  38. GC14566 CCT137690 An inhibitor of Aurora kinases and FLT3 CCT137690  Chemical Structure
  39. GC62561 CCT369260 CCT369260(화합물 1)은 항종양 활성을 갖는 경구 활성 B-세포 림프종 6(BCL6) 억제제입니다. CCT369260(화합물 1)은 520nM의 IC50을 나타냅니다. CCT369260  Chemical Structure
  40. GC33337 CDC801 CDC801은 강력한 경구 활성 포스포디에스테라제 4(PDE4) 및 종양 괴사 인자-α입니다. (TNF-α) IC50이 각각 1.1 μM 및 2.5 μM인 억제제. CDC801  Chemical Structure
  41. GC39555 CDDO-2P-Im CDDO-2P-Im은 화학 예방 효과가 있는 CDDO-Imidazolide의 유사체입니다. CDDO-2P-Im은 마우스 폐암 모델에서 폐 종양의 크기와 중증도를 감소시킬 수 있습니다. CDDO-2P-Im  Chemical Structure
  42. GC39556 CDDO-3P-Im CDDO-3P-Im은 화학 예방 효과가 있는 CDDO-Imidazolide의 유사체입니다. CDDO-3P-Im은 마우스 폐암 모델에서 폐 종양의 크기와 중증도를 감소시킬 수 있습니다. CDDO-3P-Im은 허혈/재관류(I/R) 연구에 사용할 수 있는 경구 활성 괴사 억제제입니다. CDDO-3P-Im  Chemical Structure
  43. GC35629 CDDO-dhTFEA CDDO-dhTFEA(RTA dh404)는 Nrf2를 강력하게 활성화하고 전염증성 전사 인자 NF-κB를 억제하는 합성 올레아난 트리테르페노이드 화합물입니다. CDDO-dhTFEA  Chemical Structure
  44. GC35630 CDDO-EA CDDO-EA는 NF-E2 관련 인자 2/항산화 반응 요소(Nrf2/ARE) 활성화제입니다. CDDO-EA  Chemical Structure
  45. GC32723 CDDO-Im (RTA-403) CDDO-Im(RTA-403)(RTA-403)은 PPARα에 대해 Kis가 232 및 344nM인 Nrf2 및 PPAR의 활성화제입니다. 및 PPARγ. CDDO-Im (RTA-403)  Chemical Structure
  46. GC16625 CDDO-TFEA Nrf2 activator CDDO-TFEA  Chemical Structure
  47. GC43217 CDK/CRK Inhibitor CDK/CRK inhibitor is an inhibitor of cyclin-dependent kinases (CDK) and CDK-related kinases (CRK) with IC50 values ranging from 9-839 nM in vitro. CDK/CRK Inhibitor  Chemical Structure
  48. GC62596 CDK7-IN-3 CDK7-IN-3(CDK7-IN-3)은 0.065nM의 KD를 갖는 경구 활성, 고도로 선택적인, 비공유 CDK7 억제제입니다. CDK7-IN-3은 CDK2(Ki=2600 nM), CDK9(Ki=960 nM), CDK12(Ki=870 nM)에 대한 낮은 억제를 보여줍니다. CDK7-IN-3은 종양 세포에서 세포자멸사를 유도하고 항종양 활성을 갖는다. CDK7-IN-3  Chemical Structure
  49. GC35636 CDK9-IN-7 CDK9-IN-7(화합물 21e)은 다른 CDK(CDK4/cyclinD=148 nM; CDK6/cyclinD= 145nM). CDK9-IN-7은 명백한 독성 없이 항종양 활성을 나타냅니다. CDK9-IN-7은 NSCLC 세포 사멸을 유도하고 G2 단계에서 세포 주기를 정지시키며 NSCLC의 줄기 특성을 억제합니다. CDK9-IN-7  Chemical Structure
  50. GC19096 CDKI-73 CDKI-73(LS-007)은 CDK9, CDK1 및 CDK2에 대해 각각 4nM, 4nM 및 3nM의 Ki 값을 갖는 경구 활성 및 매우 효과적인 CDK9 억제제입니다. CDKI-73  Chemical Structure
  51. GC61865 Cearoin Cearoin은 ROS의 생산과 ERK의 활성화를 통해 autophagy와 apoptosis를 증가시킵니다. Cearoin  Chemical Structure
  52. GC15083 Celastrol A triterpenoid antioxidant Celastrol  Chemical Structure
  53. GC49152 Celecoxib Carboxylic Acid An inactive metabolite of celecoxib Celecoxib Carboxylic Acid  Chemical Structure
  54. GC47070 Celecoxib-d7 An internal standard for the quantification of celecoxib Celecoxib-d7  Chemical Structure
  55. GC18392 Cellocidin Cellocidin is an antibiotic originally isolated from S. Cellocidin  Chemical Structure
  56. GN10113 Cepharanthine Cepharanthine  Chemical Structure
  57. GC52489 Ceramide (hydroxy) (bovine spinal cord) A sphingolipid Ceramide (hydroxy) (bovine spinal cord)  Chemical Structure
  58. GC52485 Ceramide (non-hydroxy) (bovine spinal cord) A sphingolipid Ceramide (non-hydroxy) (bovine spinal cord)  Chemical Structure
  59. GC52486 Ceramide Phosphoethanolamine (bovine) A sphingolipid Ceramide Phosphoethanolamine (bovine)  Chemical Structure
  60. GC43229 Ceramide Phosphoethanolamines (bovine) Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group. Ceramide Phosphoethanolamines (bovine)  Chemical Structure
  61. GC47073 Ceramides (hydroxy) A mixture of hydroxy fatty acid-containing ceramides Ceramides (hydroxy)  Chemical Structure
  62. GC43230 Ceramides (non-hydroxy) Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase. Ceramides (non-hydroxy)  Chemical Structure
  63. GC49706 Cerberin A cardiac glycoside with cytotoxic and cardiac modulatory activities Cerberin  Chemical Structure
  64. GC60688 Cereblon modulator 1 세레블론 조절제 1(CC-90009)은 동급 최초의 GSPT1 선택적 세레블론(CRBN) E3 리가제 조절제로서 분자 접착제 역할을 합니다. Cereblon modulator 1  Chemical Structure
  65. GC65487 Certolizumab pegol

    Certolizumab pegol (Certolizumab)은 인간화된 모노클로널 항체의 항원 결합 단편을 재조합하고 폴리에틸렌 글리콜화한 것으로, 특이적으로 종양 괴사 인자-α(TNF-α)를 대상으로 선택적으로 중화시키는 약물입니다.

    Certolizumab pegol  Chemical Structure
  66. GC11543 Cesium chloride Cesium chloride  Chemical Structure
  67. GC11710 CFM 4 CFM 4는 CARP-1/APC-2 결합의 강력한 소분자 길항제입니다. CFM 4는 APC-2와의 CARP-1 결합을 방지하고 G2M 세포 주기 정지를 유발하며 IC50 범위가 10-15 μM. CFM 4는 또한 약물 내성 인간 유방암 세포의 성장을 억제합니다. CFM 4  Chemical Structure
  68. GC35668 CG-200745 CG-200745(CG-200745)는 촉매 포켓의 바닥에 아연을 결합하는 하이드록삼산 부분이 있는 경구 활성, 강력한 pan-HDAC 억제제입니다. CG-200745는 히스톤 H3와 튜불린의 탈아세틸화를 억제한다. CG-200745는 p53의 축적을 유도하고, p53-dependent transactivation을 촉진하고, MDM2 및 p21(Waf1/Cip1) 단백질의 발현을 향상시킵니다. CG-200745는 젬시타빈 및 5-플루오로우라실(5-FU; )에 대한 젬시타빈 내성 세포의 민감도를 향상시킵니다. CG-200745는 세포사멸을 유도하고 항종양 효과가 있다. CG-200745  Chemical Structure
  69. GC10666 CGP 57380 CGP 57380은 2.2μM의 IC50으로 Mnk1의 선택적 억제제로 작용하지만 p38, JNK1, ERK1/2, PKC 또는 Src-like kinase에 대한 억제 활성이 없는 세포 투과성 pyrazolo-pyrimidine 화합물입니다. CGP 57380  Chemical Structure
  70. GC43234 Chaetoglobosin A Penicillium aquamarinium 추출물의 활성 성분인 Chaetoglobosin A는 cytochalasan 계열의 구성원입니다. Chaetoglobosin A  Chemical Structure
  71. GC18536 Chartreusin Chartreusin is an antibiotic originally isolated from S. Chartreusin  Chemical Structure
  72. GN10463 Chelerythrine Chelerythrine  Chemical Structure
  73. GC13065 Chelerythrine Chloride Potent inhibitor of PKC and Bcl-xL Chelerythrine Chloride  Chemical Structure
  74. GC31886 Chelidonic acid Chelidonic acid는 Chelidonium majus L의 성분입니다. Chelidonic acid  Chemical Structure
  75. GC40878 Chelidonine Chelidonine은 이소퀴놀린 알칼로이드이며 Chelidonium majus L. Chelidonine  Chemical Structure
  76. GC43236 Chevalone B Chevalone B is a meroterpenoid originally isolated from the fungus E. Chevalone B  Chemical Structure
  77. GC43237 Chevalone C 메로테르페노이드 곰팡이 대사산물인 Chevalone C는 25.00 μg/mL의 IC50 값으로 항말라리아 활성을 나타냅니다. Chevalone C  Chemical Structure
  78. GC64993 Chicoric acid 경구 활성 디카페일타르타르산인 치코릭산(Cichoric acid)은 활성산소종(ROS) 생성을 유도합니다. Chicoric acid  Chemical Structure
  79. GC15739 CHIR-124 CHIR-124는 IC50이 0.3nM인 강력하고 선택적인 Chk1 억제제이며, IC50이 6.6nM 및 5.8nM인 PDGFR 및 FLT3도 강력하게 표적합니다. CHIR-124  Chemical Structure
  80. GC43239 Chk2 Inhibitor Chk2 억제제(화합물 1)는 Chk2 및 Chk1에 대한 IC50이 각각 13.5nM 및 220.4nM인 체크포인트 키나제 2(Chk2)의 강력하고 선택적인 억제제입니다. Chk2 억제제는 강한 ATM(ataxia telangiectasia mutated) 의존성 Chk2 매개 방사선 보호 효과를 유발할 수 있습니다. Chk2 Inhibitor  Chemical Structure
  81. GC45717 Chlamydocin 곰팡이 대사산물인 Chlamydocin은 IC50이 1.3nM인 매우 강력한 HDAC 억제제입니다. Chlamydocin은 강력한 항증식 및 항암 활성을 나타냅니다. Chlamydocin은 caspase-3를 활성화하여 apoptosis를 유도합니다. Chlamydocin  Chemical Structure
  82. GC17969 CHM 1 An inhibitor of tubulin polymerization CHM 1  Chemical Structure
  83. GC35682 CHMFL-ABL/KIT-155 CHMFL-ABL/KIT-155(CHMFL-ABL-KIT-155; 화합물 34)는 매우 강력하고 경구 활성인 유형 II ABL/c-KIT 이중 키나제 억제제(각각 46nM 및 75nM의 IC50)이며, 또한 BLK(IC50=81 nM), CSF1R(IC50=227 nM), DDR1(IC50=116 nM), DDR2(IC50=325 nM), LCK(IC50=12 nM) 및 PDGFRβ(IC50= 80 nM) 키나제. CHMFL-ABL/KIT-155(CHMFL-ABL-KIT-155)는 세포 주기 진행을 정지시키고 세포자멸사를 유도합니다. CHMFL-ABL/KIT-155  Chemical Structure
  84. GC64028 Chrysosplenol D Chrysosplenol D는 3중 음성 인간 유방암 세포에서 ERK1/2 매개 세포자멸사를 유도하는 메톡시 플라보노이드입니다. Chrysosplenol D  Chemical Structure
  85. GC13408 CI994 (Tacedinaline) An inhibitor of HDAC1, -2, and -3 CI994 (Tacedinaline)  Chemical Structure
  86. GC13589 CID 755673 CID 755673은 PKD1, PKD2 및 PKD3에 대해 IC50이 각각 182nM, 280nM 및 227nM인 강력한 PKD 억제제입니다. CID 755673  Chemical Structure
  87. GC19436 CID-5721353 CID-5721353은 147μM의 Ki에 해당하는 212μM의 IC50 값을 갖는 BCL6의 억제제입니다. CID-5721353  Chemical Structure
  88. GC32997 Cinchonine ((8R,9S)-Cinchonine) Cinchonine((8R,9S)-Cinchonine)은 Cinchona 나무 껍질에 존재하는 천연 화합물입니다. Cinchonine((8R,9S)-Cinchonine)은 인간 간암 세포에서 소포체 스트레스 유발 세포자멸사를 활성화합니다. Cinchonine ((8R,9S)-Cinchonine)  Chemical Structure
  89. GC60708 Cinchonine hydrochloride Cinchonine 염산염((8R,9S)-Cinchonine 염산염)은 항말라리아 활성이 있는 Cinchona 나무 껍질에 존재하는 천연 알칼로이드입니다. Cinchonine 염산염은 인간 간암 세포에서 소포체(ER) 스트레스 유발 세포자멸사를 활성화합니다. Cinchonine hydrochloride  Chemical Structure
  90. GC52269 Cinnabarinic Acid-d4 An internal standard for the quantification of cinnabarinic acid Cinnabarinic Acid-d4  Chemical Structure
  91. GC40986 Cinnamamide Cinnamamide is an amide form of of trans-cinnamic acid and a metabolite of Streptomyces. Cinnamamide  Chemical Structure
  92. GN10189 Cinobufagin Cinobufagin  Chemical Structure
  93. GC11908 Cisplatin

    시스플라틴은 난소암, 방광암, 폐암, 자궁경부암, 두경부암, 위암 등 다양한 고체 암에 사용되는 최고의 금속 기반 항암제 중 하나입니다. 이는 널리 사용되는 최초의 금속 기반 항암제 중 하나이기도 합니다.

    Cisplatin  Chemical Structure
  94. GC17491 CITCO 이미다조티아졸 유도체인 CITCO는 선택적 구성 안드로스탄 수용체(CAR) 작용제입니다. 씨티코(CITCO)는 뇌종양줄기세포(BTSC)의 성장과 확장을 억제하고 임신 X 수용체(PXR)에 비해 EC50이 49nM이고 다른 핵 수용체에는 활성이 없다. CITCO  Chemical Structure
  95. GC35703 Citicoline 시티콜린(Cytidine diphosphate-choline)은 세포막의 성분인 포스파티딜콜린 합성의 중간체입니다. Citicoline  Chemical Structure
  96. GC31186 Citicoline sodium salt

    시티콜린 나트륨 염은 세포막의 구성 요소 인 인산 치닐 콜린 합성 중간체이며 또한 신경 보호 효과를 발휘합니다.

    Citicoline sodium salt  Chemical Structure
  97. GC43273 Citreoindole Citreoindole is a diketopiperazine metabolite isolated from a hybrid cell fusion of two strains of P. Citreoindole  Chemical Structure
  98. GC41514 Citreoviridin Penicillium citreoviride NRRL 2579의 독소인 Citroviridin은 뇌 시냅스 Na+/K+-ATPase를 억제하는 반면 마이크로솜에서는 Na+/K+-ATPase와 Mg2+-ATPase 활성을 억제합니다. 용량 의존적으로 크게 자극됩니다. Citreoviridin  Chemical Structure
  99. GC14203 Citric acid 구연산은 천연 방부제이자 음식의 신맛을 향상시키는 역할을 합니다. Citric acid  Chemical Structure
  100. GC68051 Citric acid-d4 Citric acid-d4  Chemical Structure
  101. GC16661 Citrinin

    세포사멸을 유발하는 마이코톡신

    Citrinin  Chemical Structure

Items 501 to 600 of 2215 total

페이지 당
  1. 4
  2. 5
  3. 6
  4. 7
  5. 8

내림차순